Preterm birth is multifactorial in origin, but can broadly be divided into three basic etiologies: indicated, preterm labor (PTL), and preterm premature rupture of membranes (PPROM) ( Table 1) . Indicated (iatrogenic) preterm birth, from such causes as maternal medical conditions, accounts for 25% of premature deliveries in the United States [8] . The remaining 75% accounts for spontaneous preterm birth, of which 50% is thought to be from preterm labor and 25% from PPROM. Intrauterine infection accounts for approximately 25-40% of preterm births [8, 9] . It is important to keep in mind that many of these infections are likely to present as a subclinical scenario; therefore, the pathogens responsible for these infections may be difficult to detect with conventional culture techniques [10, 11] .
Causes
Overall Percentage (%)*
Indicated (Iatrogenic) 25 Preterm Labor 50 Preterm Premature of Membranes 25
Total 100 * Intrauterineinfection accounts for approximately 25-40% of all preterm births 
Routes for intrauterine infection
Goldenberg et al. [8] , analyzed different infectious routes that lead to preterm birth. They found that infection can culminate within the uterus and amniotic fluid via hematogenous spread, incidental introduction via a diagnostic or therapeutic amniocentesis or retro grade spread from the abdominal cavity through the fallopian tubes. However, they found that infection ascending from the vagina had the highest risk factor for preterm birth (Figure 2 ). Other authors have also found that genital tract infections account for a majority of preterm births [12, 13] . Ascending infection involves a 4-step process consisting of: cervical and vaginal infection, choriodecidual infection, intra-amniotic infection, and fetal infection. One should understand that bacterial and protozoan infections ascending from the lower genital tract account for a significant cause of preterm births, not viral infections. Other infectious channels leading to intrauterine infections includematernal periodontitis [23] , as well as asymptomatic bacteruria and systemic maternal infections [19, 20] . Intrauterine infections account for roughly 50 percent of babies being born less than 28 weeks of gestation, defined as extreme preterm birth. Microbial chorioamnion invasion justifies approximately 73 percent of spontaneous preterm births before 30 weeks of gestation and only 16 percent among indicated preterm delivery without labor [14] . Histologic chorioamnionitis is inversely related to gestational age, which accounts for up to 90 percent of gestations ending at between 20 and 24 weeks [15] . Standard tocolytic therapies in patients with evidence of microbial invasion of the amniotic fluid tend to be refractory to these therapies, resulting in rapid preterm delivery [16] . This suggests that the pathophysiology of infection-associated preterm labor differs from that of idiopathic preterm labor. Of special interest, two conditions are essentially needed for intrauterine infections to cause preterm birth. The microorganisms involved must first enter the amniotic cavity and when encountered by the host immune system, be recognized as a foreign invader. After this occurs, the second process involves an unquantified number bacterial species being able to breach some threshold level in order to trigger an intraamniotic inflammatory response. This in turn induces preterm labor.
Proinflammatory cytokine prostaglandin cascade is another key player in the pathogenesis of infection associated preterm birth [17] . Fetal membranes become weakened in response to bacteria or bacterial products that produce these inflammatory mediators. This weakening can result in preterm premature rupture of membranes (PPROM). Evidence has shown that elevated concentrations of cytokines and prostaglandin's in amniotic fluid are found in patients with intraamniotic infection and preterm labor [18] . These same studies have proven that introduction of bacterial products into the amniotic fluid results in stimulation and production of proinflammatory cytokines by the uterine decidua. In turn, this stimulates the production of prostaglandins by the amnion and the decidua. These authors have also concluded that the administration of IL-1 to pregnant mice or non-human primates induces preterm labor, which can be prevented by the administration of IL-1 receptor antagonist protein [18] .
Maternal systemic infection and maternal periodontal disease have both been well-proven to induce preterm birth [19] [20] [21] . Periodontal disease is considered an anaerobic bacterial infection of the mouth, affecting up to 50 percent of pregnant women. Maternal periodontal disease has been associated with several adverse pregnancy outcomes, including preterm birth, preeclampsia, and fetal loss [19] [20] [21] . In a review of approximately 20 case reports involving preterm birth, 15 to 18 of these case reports were found to have an association with periodontal disease [22] .
The exact mechanism of why and how preterm birth results from periodontal disease is not completely understood; however, experimental evidence from studies with rabbits suggests that the oral pathogens associated with periodontitis can gain access to the systemic circulation and can be recovered from amniotic fluid [23] . These studies have also found these same pathogens within the placenta of the same hosts [23] . Of importance, gram-negative anaerobes have been widely associated with periodontitis secondary to the release of lipopolysaccharide endotoxins. These endotoxins lead to increases in the levels of proinflammatory mediators, including cytokines and prostaglandins [23] .
Intrauterine infection and preterm birth
Petit et al [24] looked at the relationship between preterm birth and intrauterine infection, which was demonstrated using animal models. His study focused on inducing their abortions by injecting bacteria or endotoxins. Similar studies have been introduced into pregnant humans which demonstrated that examination of the amniotic fluid showed the anteriority of infection over labor induction and the existence of a subclinical latency phase between these two phenomena. Several markers of the infection have been studied:
• Maternal leukocytosis >15,000/mm The main marker for the newborn is the CRP, but other markers can also be used for an early diagnosis of an infection, especially interleukin-6.
Trivedi et al. [25] looked at spontaneous labor at term versus preterm and they found that in laboring term women, a cascade resulting in the activation of the fetal adrenal axis and placental corticotropin-releasing hormone was associated. However, the exact cascade leading to preterm labor in extreme preterm births was not known. Among neonates delivered before 28 weeks of gestation, as referred to earlier in section 5.0 as extreme preterm birth, spontaneous delivery was associated with more frequent signs of placental inflammation and infection but less expression of the placental corticotropin-releasing hormone. They concluded that infection and inflammation, rather than premature activation of the fetal adrenal axis, is a big cause of extremely preterm birth in pregnant humans.
Which species of bacteria infect amniotic fluid leading to preterm birth?
Mycoplasma hominisis one of the most commonly isolated microorganisms associated with intraamniotic infection. Ureaplasma urealyticum and Fusobacterium sp. are also commonly isolated from the amniotic cavity in pregnant women who present with intactmembranes and preterm labor [26, 27] . Other microorganisms found in the amniotic fluid are listed in Table 2 . Up to 50% of patients can present with more than 1 type of species causing intraamniotic infections.
Class of Microorganism Species
Gram 
The role of lactobacilli in the vaginal microbiome
The normal human female vaginal flora consists of an ecosystem of multiple different microorganisms. Of special note, Lactobacillus species are a group of Gram-positive facultative anaerobicorganisms most commonly found in post pubertal asymptomatic female patients. On average, there are approximately 107 different lactobacilli microorganisms per gram of vaginal secretion. Figure 3 illustrates the more common Lactobacillus species, with more than 1 type of species potentially being present in any one individual [28] . Hydrogen peroxide (H2O2) production is considered the most important mechanism of bacterial antagonism of the Lactobacillus species [29] Eschenbach et al. [30] analyzed this and found that H2O2was produced in only about 35% of women with bacterial vaginosis. Those who were co-colonized with G. vaginalis and Lactobacillus species had approximately 11% of H2O2producing strains.
Bacterial vaginosis
Bacterial vaginosis is felt to be secondary to a breech in a female's normal vaginal ecosystem. This results from a reduction in the number Lactobacillus species with a replacement of anaerobic organisms [31] .Clinically, the diagnosis of bacterial vaginosis can be made using a different number of criteria available (Table 3) . Most physicians use the Amsel's criteria [32] as it is easier to utilize. Alternatively, bacterial vaginosis can be diagnosed based on the assessment of cellular morphologies of the bacteria observed in samples using criteria first introduced by Spiegel et al. [33] and then modified by Nugent et al. [34] . Nugent The perplexed relationship between bacterial vaginosis and preterm birth has been well studied. Bacterial vaginosis is associated with a risk of several obstetrical complications, such as prematurity, low birth weight, preterm pre¬mature rupture of membranes and even chorioamnionitis [36, 37] . Yet the exact etiology of why women suffer from bacterial vaginosis remains an enigma [38] . Nygren et al. [39] conducted a study where pregnant women underwent first trimester assessment of their vaginal flora via vaginal swabs and cultures. She found that those who maintained a normal vaginal flora had a 75 percent lower risk of delivery prior to 35 weeks when compared to women with abnormal vaginal flora (OR 0.26; 95% CI 0.12-0.56). Of note, she specifically noted that those patients who had an absence or reduced amount of lactobacilli along with bacterial vaginosis (BV) were associated with a two-fold increase in risk of PTB. Unfortunately, treatment of BV did not appear to consistently reduce PTB rates in her low risk patients (see section 8.1 for more details). Interestingly, those with gram positive coccus-associated aerobic vaginitis were at a three-fold increase risk of PTB (OR 3.2; 95% CI 1.2-9.1). Table 4 illustrates the different microorganisms that comprise bacterial vaginosis. 
Bacterial Vaginosis 1) Gardnella vaginalis 2) Prevotella 3) Peptostreptococcus 4) Mobiluncus 5) Bacteroides

Should asymptomatic bacterial vaginosis be treated during pregnancy?
The decision on whether pregnant women with asymptomatic bacterial vaginosis be treated with antimicrobial agents to prevent preterm birth has always been a challenging question to answer. Bacterial vaginosis is associated with intraamniotic infection and therefore is considered a risk factor for preterm delivery. However, according to the Cochrane Reviews, these do not support the concept of widespread screening for bacterial vaginosis and treatment to prevent premature delivery [40] [41] [42] . It is important to note that the most significant clinical factor in identifying women at risk for preterm birth is a history of a prior preterm birth [43] [44] Many prominent leaders in the field of perinatology and neonatology have recommended that only patients at high risk for preterm delivery should be treated with antibiotics if they are found to have bacterial vaginosis [45] . These included pregnant women with a previous history of a spontaneous preterm birth. Routine screening and treatment of BV in low-risk patients should wait until best practices for timing and methods of screening, as well as treatment of infection, have been established. According to the Centers for Disease Control and Prevention (CDC), suggestions for the treatment of BV during pregnancy are listed in Table 5 [46] . Patients should be reevaluated one month after treatment. 
Conclusion
The association between intrauterine infection and preterm birth is most commonly associated with lower genital tract infections, systemic infections and periodontal disease. One must keep in mind that not all pregnant women with these infections delivery prematurely; hence, the host inflammatory response to a potential pathogen must play a critical role in preterm birth. Cytokines play a major role in this inflammatory cascade, being brought on by the introduction of bacteria or bacterial products, such as lipopolysaccharide, into the amniotic fluid. Research around the world is being conducted to target these cytokines in animals and humans, with efforts to decrease the overall percentage of preterm births. As this percentage decreases, both neonatal mortality and morbidity will secondarily decrease. Further research is needed to better understand these context-specific pathways leading to preterm birth, as well as to develop appropriate and efficacious prevention strategies and interventions to improve survival of neonates born prematurely.
In the United States of America, we can come a long way in understanding some of the key infectious causes of preterm birth; however, I believe that our current understanding of normal vaginal microbiota, bacterial vaginosis, and the relationship to intrauterine infection and preterm birth is limited. Our understanding and knowledge on the human microbiome and its role in preventing intrauterine infections have revolved around certain medical technologies, such as DNA sequencing, allowing us to gain better assessments on the diversity and function of the microbial communities. This in turn provided a greater insight to microbial community structure, function, dynamics, and the interspecies interactions that are central to explaining how the human microbiota functions to maintain host health or predispose individuals to diseases. Lower genital tract infections, such as bacterial vaginosis, are notorious in leading to different obstetrical complications, such as preterm birth. Even though there is a debate on whether these specific patients should receive antibiotic therapy during pregnancy if they are asymptomatic, the CDC has made it very clear that all patients should receive therapy, regardless of their obstetrical history.
